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Introduction {#sec004}
============

The prevalence of Autism Spectrum Disorder (ASD) has been increasing \[[@pone.0236994.ref001]\], up to 1:54 in recent CDC reports. It is a disorder which affects 1 in 42 males and 1 in 189 females \[[@pone.0236994.ref002]\]. ASD is a neurodevelopmental disorder that is characterized by deficits in social behaviors and communication skills, as well as the presence of certain stereotyped or repetitive behaviors and/or interests \[[@pone.0236994.ref001]\]. A definitive diagnosis of ASD is typically made by the age of two to three, although signs of the disorder may be seen earlier \[[@pone.0236994.ref003]\]. ASD is caused by a variety of both genetic and environmental factors \[[@pone.0236994.ref004], [@pone.0236994.ref005]\] and it is associated with brain insult and inflammation \[[@pone.0236994.ref006]\]. Prematurity, defined as a baby born before the 37th week of gestation, has been identified as one environmental risk factor for ASD, either as a primary risk factor or an additional risk in families with a sibling with ASD \[[@pone.0236994.ref007]\]. Even though the call for action in the publication \"*Born Too Soon*: *The Global Action Report on Preterm Birth\"* in 2012 reported that in 2010, approximately 1 in 10 babies was born prematurely, the incidence of prematurity did not change significantly in Israel (7.8--7.4% in 2015) \[[@pone.0236994.ref008]\], and continued to rise in USA with 11.5% reported in 2012 \[[@pone.0236994.ref009]\].

Thus, this population of prematurely born children warrants further investigation due to their significant risk of developmental delay. Common consequences of prematurity include medical complications shortly after birth \[[@pone.0236994.ref010]\] as well as neuromuscular disorders such as cerebral palsy, intellectual disability, and respiratory conditions \[[@pone.0236994.ref009]\]. It has been shown that routine neonatal follow up is the best way to monitor neurodevelopmental progression in babies born prematurely \[[@pone.0236994.ref011]\]. Certain factors, such as male gender, cerebral palsy, and low birth weight, have been shown to correlate with poor neurodevelopmental outcome in premature infants \[[@pone.0236994.ref012]\].

ASD has been known as a disability with a gender skew, with males predisposed to receive a diagnosis of ASD up to three to four times more than females \[[@pone.0236994.ref013]\]. This could be due to an under-diagnosis of females with autism \[[@pone.0236994.ref014]\], or to a true male gender genetic tendency and vulnerability. Comorbidities including other neurologic disorders and developmental disorders are common \[[@pone.0236994.ref015]\], such as Cerebral Palsy (CP) and global developmental disability (GDD) \[[@pone.0236994.ref016]\]. Studies have shown that there is a higher incidence of ASD in patients with non-spastic CP \[[@pone.0236994.ref017]\] and the comorbidity of ASD and GDD is well established.

It has been shown that when two conditions appear together, the symptoms are more severe \[[@pone.0236994.ref018]\]. The link between earlier gestational week and increased risk of autism was proven in prior studies, however the correlation was defined in three prematurity defined categories (24--26 weeks--extremely low gestational age infants; 27--33 weeks--preterm infants; 34--36 weeks--late preterm infants) as compared to two term categories (37--41 weeks--term infants; 42 weeks--post-term infants) and with each earlier group, the risk was higher. However, the groups were not clumped per weeks but per number of children and the results represent risk per category (two weeks between 24--26 weeks and for six weeks between 27--33 weeks) and without gender differences \[[@pone.0236994.ref019]\].

Other studies suggesting a link between prematurity and autism use birth weight as proxy, \[[@pone.0236994.ref020], [@pone.0236994.ref021]\] however, birth week does not correctly represent prematurity level as related to brain maturity, and even birth weight at term was found to be related to autism risk \[[@pone.0236994.ref022]\].

In this study, we aimed to identify whether there is a correlation between the birth week and a diagnosis of ASD, and if there is a gender predisposition in this correlation. Additionally, we compared it to two common diagnoses in prematurity---of CP and GDD, in a cohort of children born prematurely in Israel, and followed at one tertiary referral center.

Materials and methods {#sec005}
=====================

This study was performed at the prematurity clinic of the Weinberg Child Development Center, Edmond and Lilly Safra Children's Hospital, Tel Hashomer, which is the largest referral center in Israel and linked to a tertiary prematurity unit.

Infants born below 36 weeks are referred for neurodevelopmental follow-up at 4--8 weeks after discharge. As such, the cohort is unbiased by the subsequent diagnoses. Patient data was recorded following patient visits. Data from 2011--2017 was examined retrospectively for all infants at least two years of age at the completion of the study, and their developmental follow-up assessments were documented. After the cohort of babies born prematurely was established, diagnoses were identified. Though a definitive diagnosis of ASD is given around the age of two to three years, patients who have normal development through the age of two years are oftentimes discharged from care at the development centers. Therefore, we only included patients who were examined until at least the age of two years in order to account for some potential loss due to follow up. Of interest in this cohort were diagnoses of ASD, as compared to diagnoses of Global Developmental Delay (GDD), and Cerebral Palsy (CP). A diagnosis of ASD was given based on DSM-IV-TR or DSM-5 criteria \[[@pone.0236994.ref023], [@pone.0236994.ref024]\]. The Autism Diagnostic Observation Schedule---ADOS \[[@pone.0236994.ref025]\] was used to confirm diagnoses. Children also underwent a neurodevelopmental evaluation \[[@pone.0236994.ref026]\]. A Developmental Quotient (DQ) score was obtained for each child based on the Denver Developmental Screening Test, second edition (DDST II); \[[@pone.0236994.ref027]\] and the Clinical Adaptive Test/Clinical Linguistic and Auditory Milestone Scale (CAT/CLAMS) \[[@pone.0236994.ref028]\]. Other diagnoses such as global developmental delay and cerebral palsy were made according to standardized diagnostic tools including neurodevelopmental examination and neuropsychological evaluation. Specifically, a diagnosis of GDD was based on delays by more than 2 SD in two or more developmental areas (DQ \< 70), both on neurodevelopmental examination and neuropsychological evaluation \[[@pone.0236994.ref029]\]. A diagnosis of CP was made by the Pediatric Neurologist based on neurological examination, imaging and Gross Motor Function Classification System, according to diagnostic guidelines \[[@pone.0236994.ref030]\].

All participants underwent standardized cognitive testing. Specific instruments selected for cognitive testing were dependent on the child\'s age and functioning level. Instruments used included the Bayley Scale of Infant Development- second edition (BSID-II) \[[@pone.0236994.ref031]\], Mullen Scales for Early Learning (MSEL) \[[@pone.0236994.ref032]\], or a cognitive test such as the Stanford-Binet Fourth Edition (SB-4) \[[@pone.0236994.ref033]\], Wechsler Preschool and Primary Scale for Intelligence--Third Edition (WPPSI-III) \[[@pone.0236994.ref034]\], Wechsler Intelligence Scale for Children--Revised (WISC-R) \[[@pone.0236994.ref035]\], or Kaufman Brief Intelligence Test (K-BIT) \[[@pone.0236994.ref036]\]. Diagnoses were analyzed according to birth week and gender.

Ethical approval {#sec006}
----------------

The study has been approved by the appropriate institutional research ethics committee \"Sheba Medical Center\" Institution Review Board- Helsinki approval number is 3592-16- SMC. For this type (retrospective) of study, formal consent is not required.

Statistical analysis {#sec007}
--------------------

In order to examine the association between birth week, gender and diagnoses, we used a Wilcoxon test for multiple comparisons assuming non parametric distributions. In addition, a nominal logistic model was fit using the following factors: gender, birth week and birth week X gender interaction. In order to examine the relationship between birth week and birth weight we fit a linear regression model. All statistical analyses were conducted using SPSS version 21 and JMP Pro14 By SAS.

Results {#sec008}
=======

Of the 838 children identified who were born premature, 416 children were seen after the age of two years; 422 children were excluded. Of the excluded 229 (54.3%) were male, and 193 (45.7%) were female. The average birth week was 32.3 weeks (SD = 2.5) and the average birth weight was 1670 grams (SD = 486), which is significantly higher compared to children who were seen after the age of two years, t(834) = 7.26, p\<0.001, t(819) = 6.65, p\<0.001, respectively.

Of the 416 children seen after the age of two years, 246 (59.1%) were male, and 170 (40.9%) were female. 177 (42.5%) of the premature children were twins (4 of them identical), and seven (1.7%) from triplet pregnancies. With an age range from 2--14.2 years old, the average age was 4.2 years (SD = 2). Birth week ranged from week 24--37, with an average of 30.8 weeks (SD = 3.3). Birth weight ranged from 368--3550 grams, with an average of 1427 grams (SD = 557). The relationship between birth week and birth weight exhibited a significant (*p\<0*.*001*) linear correlation for both males and females using a linear regression model. Of the 416 children, 43 (10.3%) received a diagnosis of ASD, 62 (14.9%) received a diagnosis of CP and 68 (16.3%) received a diagnosis of GDD. Additional diagnoses such as ADHD are usually decided after the age of four years and more significantly at school-age. Accordingly, our cohort is limited and we will report only on the three major diagnoses--ASD, CP and GDD.

There was a significant difference in the probability of ASD diagnosis, CP and GDD between birth weeks *Ҳ^2^ (13) = 22*.*5*, *p \<* .*05*, *Ҳ^2^ (13) = 86*.*7*, *p \<* .*001*, and *Ҳ^2^ (13) = 26*.*5*, *p \<* .*05*, respectively. The rates of ASD and GDD had higher percentage of babies born no later than week 29 diagnosed with these disorders. The rates of CP are increased with earlier prematurity and decreased by weeks 32 (See [Fig 1](#pone.0236994.g001){ref-type="fig"}).

![Rates of diagnosis of ASD, GDD, and CP by specific birth week.](pone.0236994.g001){#pone.0236994.g001}

The primary outcome in this study was a diagnosis of ASD. Of the patients with ASD, 27 (62.8%) were males and 16 (37.2%) were females. The average age of the patients in the cohort was 5.7 years old (SD = 2.2). The age of initial ASD diagnosis was in the range of 1.1--8.5 years, with mean age of 3.5 years (SD = 1.8). Of the 43 children with ASD, 19 (44.2%) were twins. The average birth week was 30.2 weeks (SD = 3.7) and the average birth weight of the patients with ASD was 1415 grams (SD = 704). When tested for both male and female, it appears that the probability for ASD increases with earlier birth weeks: There is an increased probability of ASD with each reduction in the week of prematurity between the weeks of 25 to 31, with the probability of ASD at 22.6% at 25 weeks versus 6% at 31 weeks, *Wilcoxon approximately Z = 2*.*1*, *p\<0*. *05*. Moreover, early ranges of birth weeks are significantly different from later ones. Weeks 25--26 have a higher probability of ASD-- 20%-22.6%, as compared to weeks 27--37, with a probability of 8.1%-13% (except week 30 with 3.8% and week 31 with 6%). (See [Table 1](#pone.0236994.t001){ref-type="table"} and [Fig 1](#pone.0236994.g001){ref-type="fig"}).

10.1371/journal.pone.0236994.t001

###### Number and percentage of children receiving a diagnosis of ASD by gender based on birth week.

![](pone.0236994.t001){#pone.0236994.t001g}

  Birth week (n:M,F)        ASD MALE     ASD FEMALE   TOTAL ASD
  ------------------------- ------------ ------------ ------------
  24 (n = 4:2,2)            0 (0%)       0 (0%)       0 (0%)
  25 (n = 31:15,16)         2 (13.3%)    5 (31.3%)    7 (22.6%)
  26 (n = 15:7,8)           1 (14.3%)    2 (25%)      3 (20%)
  27 (n = 27:16,11)         0 (0%)       3 (27.3%)    3 (11.1%)
  28 (n = 36:24,12)         2 (8.3%)     1 (8.3%)     3 (8.3%)
  29 (n = 23:10,13)         2 (20%)      1 (7.7%)     3 (13%)
  30 (n = 26:16,10)         0 (0%)       1 (10%)      1 (3.8%)
  31 (n = 50:30,20)         2 (6.7%)     1 (5%)       3 (6%)
  32 (n = 54:34,20)         5 (14.7%)    0 (0%)       5 (9.3%)
  33 (n = 32:17,15)         4 (23.5%)    0 (0%)       4 (12.5%)
  34 (n = 55:35,20)         4 (11.4%)    1 (5%)       5 (9.1%)
  35 (n = 37:24,13)         3 (12.5%)    0 (0%)       3 (8.1%)
  36 (n = 17:9,8)           1 (11.1%)    1 (12.5%)    2 (11.8%)
  37 (n = 9:7,2)            1 (14.3%)    0 (0%)       1 (11.1%)
  TOTAL (n = 416:246,170)   27 (10.9%)   16 (9.4%)    43 (10.3%)

\*The percentages in parentheses represent rations of same week and gender, and thus do not add up to total ASD count.

We examined the extent to which gender contributed to the findings. There was a statistically significant difference between birth week of females born prematurely with ASD (M = 27.9, SD = 3.4 weeks) versus females born prematurely who did not receive a diagnosis of ASD (M = 30.9, SD = 3.2 weeks), *t(168) = 3*.*60*, *p \<* .*001*. On the contrary, there was no significant difference between birth week in males born prematurely with ASD (M = 31.7, SD = 3.2 weeks) as compared to males born prematurely who did not receive a diagnosis of ASD (M = 31.1, SD = 3.3 weeks), *t(244) = 0*.*99*, *p\>*.*05*.

In order to compare multiple pairs of ASD versus birth week, we performed a multiple comparisons Wilcoxon test. When gender was taken into account, it is clear that the significance for early birth week and higher probability of ASD is observed in females. There is a significant increase in rates of ASD in earlier weeks for females; *Ҳ^2^ (13) = 44*.*6*, *p \<* .*001*. However, for males there was an elevated probability, between 6.7% to 23.5%, regardless of level of prematurity, with no significance *Ҳ^2^ (13) = 6*.*6*, *p\>*.*05* (See [Table 1](#pone.0236994.t001){ref-type="table"} and [Fig 2](#pone.0236994.g002){ref-type="fig"}). For females there is increased probability with each reduced week of prematurity between weeks 25 and 32, with the probability of ASD at 31.3% in 25 week versus 0% at 32 week, *Wilcoxon approximately Z = 2*.*7*, *p\<0*. *01*. Weeks 25--27 have a significantly higher probability of ASD-- 25%-31.3%, as compared to weeks 31--35, with a probability of 0%-5%, p value range between 0.001 to 0.03.

![Differences in rates of ASD between males and females by birth week.](pone.0236994.g002){#pone.0236994.g002}

The proportion of children with ASD born below 33 weeks was 41% of all ASD for boys and 32% for girls, almost 1:1 ratio, however- after 33 weeks, 20% for males and 4% for females, reminding the known 1:5 male/ female ratio of idiopathic autism \[[@pone.0236994.ref037]\] (See [Table 1](#pone.0236994.t001){ref-type="table"}).

On top of the multiple non parametric comparisons for each pair using the Wilcoxon method, we constructed a nominal logistic model with the following factors: gender, birth week and the interaction of those effects. The model was significant *Ҳ^2^(3) = 13*.*30*, *p\<0*.*01* as well as the main effect for birth week *Ҳ^2^(1) = 4*.*61*, *p\<0*.*05*, and the interaction effect, *Ҳ^2^(1) = 9*.*53*, *p\<0*.*01*. The main effect for gender was not significant *Ҳ^2^(1) = 2*.*18*, *p\>0*.*05*. For females we can see that as the week birth increases, the proportion for ASD reduces. For males, the picture is different: the proportion of ASD remains relatively constant. However, in earlier birth weeks, the risk for ASD is higher for females than males. As we move towards birth week 28 the proportion evens out, with the rate becoming slightly higher for males in the last increment (See [Fig 3](#pone.0236994.g003){ref-type="fig"}).

![Probability of ASD of males and females by birth week.](pone.0236994.g003){#pone.0236994.g003}

68 children (16.3%) received a diagnosis of GDD, thirteen of them have ASD (19%). Adding the GDD as an intervening factor to the model, strengthened the model slightly *Ҳ^2^(6) = 22*.*81*, *p\<0*.*001* and the GDD is significant *Ҳ^2^(1) = 6*.*48*, *p\<0*.*05* as well as its interaction with birth week and gender *Ҳ^2^(1) = 4*.*22*, *p\<0*.*05*. When constructing a graph based on the nominal logistic model prediction, we see that while for females trends remain similar, the proportion of ASD drops as birth week increases. For females with GDD, the same trend is kept but with a higher propensity towards ASD. For males however, trends reverse. While for males without GDD the trend is relatively constant across birth weeks, for males with GDD the proportion of males with ASD increases with birth week (See [Fig 4](#pone.0236994.g004){ref-type="fig"}).

![Probability of ASD of males and females with or without GDD by birth week.](pone.0236994.g004){#pone.0236994.g004}

Additionally we examined the birth weight. There was a statistically significant difference between birth weight of girls born prematurely with ASD (M = 1009, SD = 532) as compared to girls born prematurely who did not receive a diagnosis of ASD (M = 1350, SD = 504), *t(167) = 3*.*56*, *p \<* .*05*. On the contrary, there was no significant difference between birth weight of males born prematurely with ASD (M = 1656, SD = 690 weeks) when compared to males born prematurely who did not receive a diagnosis of ASD (M = 1482, SD = 556), *t(243) = 1*.*48*, *p\>*.*05*.

We also examined IUGR/ SGA. Thirty seven children had IUGR/ SGA, 20 were males (54%) and 17 were females (46%). Birth week ranged from week 24--37, with an average of 30.8 weeks (SD = 3.9). Birth weight ranged from 580--2200 grams, with an average of 1130 grams (SD = 448).

No correlation was found between IUGR/SGA and ASD, *Ҳ^2^ (1) = 0*.*2*, *p\>*.*05*., Thirty four of IUGR without ASD (92%) and 3 IUGR with ASD (8%). In order to examine whether IUGR had an effect on the results we exclude these 37 children from model. The model was significant *Ҳ^2^(5) = 17*.*74*, *p\<0*.*01*, effect for IUGR was not significant *Ҳ^2^(1) = 0*, *p\>0*.*05* and the conclusions remained the same: the probability to ASD decreased for females with each birth week progress while for males it remained relatively constant.

We also identified whether the births were multiples or singletons. For the purpose of the statistical analysis, the twins and triplets were combined into a single group. Of all the premature infants in the cohort, 31% of twins were born in weeks 32--33, 24% born in weeks 30--31, and 22.8% born in weeks 34--35. Compared with the singleton births, there was a significant difference in the birth week, *t(411) = 3*.*9*, *p\< 0*.*001*.Mean birth week of singletons was 31.5 (SD = 2.7) versus 30.3 weeks (SD = 3.6) in multiple pregnancies. Out of 184 multiple pregnancies 19 had ASD (10.3%). We examined the distribution of the proportion of multiple pregnancies with ASD across birth weeks, but no particular significance was found between earlier and later birth weeks, nor were we able to construct a significant model indicating twins as a significant intervening factor Ҳ^2^ (1) = 1.52, p\>.05.

There was no significant difference found between birth weight of singletons when compared to multiple pregnancies, *t(411) = 1*.*5*, *p\> 0*.*05*.

Discussion {#sec009}
==========

In this large scale study examining the correlation between autism and prematurity in Israel, we found a much higher prevalence---10.3% of ASD in the premature population compared to the known general incidence of 1.2--2%. This demonstrates that prematurity is a clear risk factor for the development of ASD. A large-scale study undertaken in Sweden in 2011 found a significant association between autism and prematurity, however they focused on the entire category of prematurity (i.e. born before 37th week of gestation) \[[@pone.0236994.ref038]\]. In our study, we separated the children by week of birth and by gender, revealing a significant increase in the rates of ASD with each week that the child was born earlier, especially before 31 weeks. The degree of prematurity was influenced more strongly by female gender, to the degree that the male to female ASD ratio is almost 1:1. However, after 33 weeks the incidence remains elevated and does not continue to decrease, following the pattern of increased risk in males, in the same gender distribution as \"idiopathic\" autism \[[@pone.0236994.ref039]\]. As demonstrated in Chart 1, there was a significant correlation between the birth week and diagnosis of ASD only during extreme prematurity. The main contribution to the decreasing slope is driven by female gender, thus males are at an elevated risk regardless of the level of prematurity, which is what has been seen in the literature until now \[[@pone.0236994.ref040]\]. This change in the slope tendency and the gender differences elute to a "double hit" theory in regards to prematurity and autism risk, with a higher vulnerability in premature males, possibly related to a genetic predisposition. In other words, girls are mainly at risk because of being born premature and boys are more predisposed by their gender, and are at a significantly elevated risk even at near-term. Differential brain vulnerability to prematurity based on sex differences was shown in other studies, and there is a clear differential gender vulnerability to complications of prematurity \[[@pone.0236994.ref041]\] such as retinopathy \[[@pone.0236994.ref042]\].

Brain gender differences in autism have been revealed as well. Sex differences in ASD are associated with cortical regions involved in language and social function \[[@pone.0236994.ref043]\]. Based on gender influence on prematurity complications and female and male differential brain development in autism, we may presume that prematurity complications may have a different influence on female preterm extrauterine brain maturation and development. This assumption may allude to the differential need for neuroprotection measures in boys and in girls born prematurely.

A limitation of our study is that we are a referral center, and therefore we lost some patients to follow up, and there are differences by birth weight and week between the group, due to the fact that parents to premature infants at less risk, tend so arrive less to follow ups. Thus, it is possible that some of these children who were born prematurely were followed by primary care centers, especially for the less concerning group of patients born near-term (36--37 weeks) and with higher birth weight. An additional limitation is that almost half of the cohort were twins. Although analyzed separately and born significantly at earlier weeks than singletons, it is possible that some of the twins were monozygotic and as such have an additional reason for increased ASD risk \[[@pone.0236994.ref044], [@pone.0236994.ref045]\].

A third limitation is the lack of knowledge of the true incidence of ASD in Israeli children born at term. For this group there is an intrinsic referral bias to our center, and therefore it would be important in future studies to concurrently follow a term group from birth as we followed the premature infants. Our reference to compare the incidence of ASD in Israeli population is not recent enough, and does not reflect the increase in incidence published by the CDC for the study period \[[@pone.0236994.ref002], [@pone.0236994.ref046]\].

What this study demonstrates is that there is indeed a correlation between prematurity and autism, at any degree of prematurity. Early intervention has been shown to have significant impact on the prognosis and functioning of children with autism. Specifically, the earlier intervention is begun, the more impactful it is on the functioning of the child. It is important to be aware of prematurity as a significant risk factor for the development of ASD, and include ASD screening in each follow up of those infants born prematurely, until at least three years of age.

Because of the large size of our cohort, we were also able to look at the differences between singleton births and multiple births. We found that there was a significant difference in the birth week between singletons and multiples, specifically that multiple births occurred earlier. While this is not necessarily new information, it is indicative of the need to improve maternal health as it relates to multiple birth pregnancies. Additionally, since we have shown that prematurity is a risk factor for ASD, and since we know that multiple births carry a higher risk of prematurity \[[@pone.0236994.ref003]\], there is a greater need to monitor twins for longer periods of time to assure appropriate development.

Future areas of research will need to focus on eliminating some of the variables that might have affected our study. For instance, by following babies prospectively from birth, it is hopeful to eliminate some of the loss due to follow up. Additionally, the etiology of ASD is multifactorial. It will be important to compare key characteristics that can help with screening in children with ASD who were born premature versus children with ASD who were born at term and observe long term outcome as well. For example, one prospective study looked at very low birth weight (\< 1500 g) infants born prematurely, and found that according to the M-CHAT test, 26% of them were likely to develop autism \[[@pone.0236994.ref047]\]. This is a significant finding, and by undertaking a study with a larger cohort (similar to the current research), we hope to strengthen this claim.

Additionally, one area of research that is currently of utmost importance in the field of autism is understanding the relationship between genetics and the development of the disorder, with the possibility of prematurity as a \'double hit\' when there is a genetic predisposition. By examining this population of children with ASD who were born prematurely, looking at other familial risk factors such as siblings with ASD who were not born prematurely, we might be able further elucidate the nature versus nurture influences. It has been shown that there is a genetic risk of autism \[[@pone.0236994.ref048]\], and our study may provide additional insight into gender specific development of ASD. This research supports the existent recommendations for early intervention, especially for those children born prematurely \[[@pone.0236994.ref049],[@pone.0236994.ref050]\], hopefully leading to better outcomes.
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ADHD

:   Attention Deficit/ Hyperactivity Disorder

ADOS

:   Autism Diagnostic Observation Schedule

ASD

:   Autism Spectrum Disorder

BSID-II

:   Bayley Scale of Infant Development- second edition

CAT/CLAMS

:   Clinical Adaptive Test/Clinical Linguistic and Auditory Milestone Scale

CP

:   Cerebral Palsy

DDST-II

:   Denver Developmental Screening Test, second edition

DQ

:   Developmental Quotient

GDD

:   Global Developmental Delay

K-BIT

:   Kaufman Brief Intelligence Test

LIPS-R

:   Leiter International Performance Scale---Revised

MSEL

:   Mullen Scales for Early Learning

SB-4

:   Stanford-Binet Fourth Edition

WISC-R

:   Wechsler Intelligence Scale for Children--Revised

WPPSI-III

:   Wechsler Preschool and Primary Scale for Intelligence--Third Edition
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The [PLOS Data policy](http://www.plosone.org/static/policies.action#sharing) requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data---e.g. participant privacy or use of data from a third party---those must be specified.

Reviewer \#1: No

Reviewer \#2: Yes

Reviewer \#3: No

\*\*\*\*\*\*\*\*\*\*

4\. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer \#1: Yes

Reviewer \#2: Yes

Reviewer \#3: Yes

\*\*\*\*\*\*\*\*\*\*

5\. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer \#1: This study examines the association of ASD with preterm birth in 416 children from the ages of 2 to 11 years. More specifically, the authors seek to investigate the possibility of a gestational age gradient such that the risk of ASD decreases with each week of gestation from 24 to 37 weeks (from the lower boundary of extremely preterm to the upper boundary of later preterm) and how such a gradient might differ between males and females. They find that females have a significantly increased risk of ASD relative to males at lower gestational ages, whereas males maintain the same risk of ASD regardless of degree of prematurity.

Comments

1\. The authors' claim that such a gestational age gradient "has not been evidenced" in prior studies is inaccurate. At least two prior studies have demonstrated such a gradient (by week) with much larger epidemiological samples and with adjustment for a number of critical covariates and confounding variables that were not considered in the current study, presumably because the small sample size precluded their inclusion in statistical analyses. Please see Kuzniewicz et al., 2014 and Xie et al. (2017). In addition, Talmi et al. (2020) recently conducted a retrospective national cohort study of all children born in Israel from 2000-2012 using gestational age categories of extreme, very, moderate, and late preterm, showing a clear-cut gestational age gradient, as have a number of other large European population studies over the past decade, none of which are cited by the authors.

2\. The authors do not adequately address the loss to follow up of more than half of the sample (n=871) that was referred to them and the potential bias that this introduces into their results. At the very least, demographic and birth characteristics between those retained and those lost should be compared.

3\. Fetal growth restriction has been found to contribute, independently of gestational age, to ASD risk in a number of high-quality studies. The lack of consideration of FGR/SGA in this study is problematic, especially in that FGR may represent a distinct preterm phenotype that confers ASD risk by different mechanisms than GA.

4\. The large age range is somewhat problematic in that the preterm ASD phenotype is not well characterized. ASD classifications in the youngest children, whether positive or negative, may not be stable.

5\. It is now standard in autism epidemiological research to investigate ASD with and without intellectual disability (ID), as these are likely to differ to in etiology. The small sample size of the current study may have precluded meaningful statistical analysis addressing ID, but these data could have been presented for descriptive purposes. For example, one wonders how many of the EPT/VPT girls with ASD had ID and severe ID. The authors list a large number of cognitive measures, but they do not use these to describe their sample.

6\. The authors state that all ASD diagnoses were confirmed with the ADOS, but do not report any ADOS data, for example, the Modules used -- which would have given a better sense of the level of function in the sample -- or the severity scores for repetitive behaviors as well as social communicative impairment. These data are of interest in the characterization of any preterm ASD sample, given that the ADOS, a gold-standard measure, has rarely been used to characterize ASD in premies.

7\. The rationale for investigating the GA gradient for global development delay (GDD) and CP in addition to ASD is not clearly or compellingly explained. It is not clear if these are overlapping or mutually exclusive groupings, although the latter seems to be the case. In addition, it is not reported if any of the children classified as ASD had severe ID or severe gross motor impairment. This is problematic in that DSM-5 excludes an ASD diagnosis that is "better explained by intellectual disability (intellectual developmental disorder) or global developmental delay", and it is not uncommon for EPT-born children to have this severity of ID. In addition, severe motor impairment (e.g., a Gross Motor Function Classification of Score = 5) could result in autism-like symptoms because of an inability to orient, direct attention, show, use gestures, etc.

8\. The authors do not adequately account for multiple birth in their statistical analyses. Approximately, 44% of the sample and 44% of those diagnosed with ASD were multiples, with the large majorities of those twins. (Information on monozygosity was not available.) T-tests and chi-squares are used to analyze differences between singletons and multiples in mean GA and distributions by gestational age, respectively, but the results are difficult to follow and the authors do not offer a clear interpretation. It would seem more effective to have included this variable as a covariate in the logistic regression analysis. I also wondered how many of those classified with ASD were from the same birth.

9\. It seems necessary to consider that the present findings are unreliable, given the small sample size and the inconsistency of the findings from a number of prior studies, which are not addressed in this report. It is notable, however, that others (e.g., Schendel & Bhasin; Xie et al., 2014) have found that females are at relatively higher risk of ASD with ID vs. without ID than males, which may bear on the current findings, if ID were taken into account.

Reviewer \#2: This manuscript explores the relationship of birth week among premature infants to Autism Spectrum Disorder (ASD), to see if the degree of prematurity might predict the likelihood that ASD might develop. 416 children born from 2011 to 2017, from an original cohort of 871 premature children, followed for at least two years were studied retrospectively, looking at birth week and gender. All children were from a single child development referral center in Israel. Nearly half were twins or triplets, some of whom may have been monozygotic. The authors acknowledge that this may have affected the risk for developing ASD. A total of 43 children were felt to have ASD, and the risk was greatest for those who were more premature. While the overall risk of developing ASD is greater for males than females, an elevated risk of ASD with lower birth week was greatest for females, who had a higher risk than males for lower birth weeks and a lower risk than males for higher birth weeks. For males, the risk was relatively stable across the range of birth weeks.

ASD is felt to be due to a combination of genetic and environmental factors, with brain insult and inflammation possibly contributing to the risk of developing it. Factors related to premature birth may contribute to the environmental components contributing to the development of ASD. Lower birth weight correlated with ASD risk in females, but not in males. A possible correlation between Cerebral Palsy (CP) and Global Developmental Delay (GDD) was also looked for. Measurements of ASD, CP and GDD by gender are shown across the range of birth weeks in the Figures 1-3. Table 1 summarizes the incidence of ASD by gender and birth week. A number of measures of cognitive function were utilized. Statistical analysis was appropriate.

This study shows that prematurity is a risk factor for the development of ASD, and provides additional information regarding the relative risk attributable to birth week and gender. It is beyond the scope of this study to look at specific factors that might contribute to the risk of ASD in premature children, such as anoxic brain damage, intraventricular hemorrhage, presence or absence of Retinopathy of Prematurity (ROP), and treatment of Type 1 ROP with anti-VEGF injections. What can be said is that earlier intervention for those developing ASD may contribute to better outcomes, and recognition of the increased risk of ASD in premature children is therefore important. It is an interesting study.

Reviewer \#3: This is an interesting study with a retrospective look at prematurity and gender risk for ASD. There are several things that can strengthen it to make it more meaningful to autism researchers, clinician, and parents.

Abstract: Children were followed for only "at least" two years, so the statement about girls should may need to be tempered to say that this relationship is evident only for girls whose symptoms are sufficiently apparent to be diagnosed by the age of 24 months, if that was the case (no info is given on when they were diagnosed). Girls with higher cognitive and language abilities are often not diagnosed until much later.

Introduction: When the manuscript is revised, the CDC prevalence data needs to be updated to 1:54. "significant risk of developmental risk" may need to be revised -- is developmental delay the intended meaning?

Please clarify when the children were evaluated. It is stated that you only included children seen in the clinic up to the age of 2 to prevent loss to follow up, but several of the cognitive measures listed are for older children only. At what ages where the cognitive evaluations completed? It is apparent from the age range (2-14.2 years) that cognitive testing may have occurred at any point. This is a retrospective study, so presumably cognitive testing was done for a reason unrelated to the study, which should be addressed at least briefly to determine possibility of bias in the sample. For example, if the cognitive testing was performed as a matter of routine follow up for a premature child, that is less biased than if they were only performed when disability was suspected, introducing at least some selection bias in the sample. This issue is also related to the comment above about females across the spectrum who are typically not diagnosed until later in life.

How old were the children when they were diagnosed? That is an important proxy for interpretation of the severity of the ASD.

Also, it would be helpful to know co-morbid diagnoses. Co-morbidity data would also aid in the interpretation of the findings. Are the females diagnosed with ASD in the lower gestational ages also affected by multiple disabilities or is ASD the primary risk? All of this information is more helpful than a blanket statement about risk and females as if they are all equivalent in terms of ASD. The current data are helpful, but MORE data from the records would significantly improve the interpretation and application of the study. Since Cognitive testing was completed, that is one example of data that aids in interpretation. Females with Intellectual Disability (ID) present very differently than females without ID, and may or may not have been identified yet to be included in the ASD data.

Line 204 \-- What is the reference for "1:5 male/ female ratio of idiopathic autism"? And is this stated correctly? This sentence is used following presentation of the data of 20 males with ASD in the more advanced pregnancies compared to 4 females.

Line 265 -- typo "especially form the less concerning group of patients born," there are other suspected typos throughout. (e.g. line 367 intervention. In: es, I., Levine J, editor. Neuroprotection in Autism, Schizophrenia and. . . )

Discussion: The discussion somewhat buries the lead in the statement (line 254) "However, after 33 weeks the incidence remains elevated and does not continue to decrease, following the pattern of increased risk in males, in the same gender distribution as \"idiopathic\" autism (33)"

Following that, it is surprisingly light on discussion of females with ASD, which is a very current topic in the autism community right now. Since the discussion acknowledges that the finding of sustained risk for males not only in prematurity but throughout gestation time is not novel, I think more discussion about the meaning of the finding for females is expected here, as that is the novel finding and the title of the article. Much is made of the findings for multiple births, which is also less than novel.

\*\*\*\*\*\*\*\*\*\*

6\. PLOS authors have the option to publish the peer review history of their article ([what does this mean?](https://journals.plos.org/plosone/s/editorial-and-peer-review-process#loc-peer-review-history)). If published, this will include your full peer review and any attached files.
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**Do you want your identity to be public for this peer review?** For information about this choice, including consent withdrawal, please see our [Privacy Policy](https://www.plos.org/privacy-policy).

Reviewer \#1: No

Reviewer \#2: Yes: Michael William Gaynon MD

Reviewer \#3: No

\[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link \"View Attachments\". If this link does not appear, there are no attachment files to be viewed.\]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, <https://pacev2.apexcovantage.com/>. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at <figures@plos.org>. Please note that Supporting Information files do not need this step.

10.1371/journal.pone.0236994.r002

Author response to Decision Letter 0
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Here are our specific corrections and comments:

\# Academic editor

PONE-D-19-35927

Autism risk linked to prematurity is more accentuated in girls

PLOS ONE

Journal requirements:

When submitting your revision, we need you to address these additional requirements:

1\. Please ensure that your manuscript meets PLOS ONE\'s style requirements, including those for file naming. The PLOS ONE style templates can be found at <http://www.plosone.org/attachments/PLOSOne_formatting_sample_main_body.pdf> and <http://www.plosone.org/attachments/PLOSOne_formatting_sample_title_authors_affiliations.pdf>

2\. We note that you have stated that you will provide repository information for your data at acceptance. Should your manuscript be accepted for publication, we will hold it until you provide the relevant accession numbers or DOIs necessary to access your data. If you wish to make changes to your Data Availability statement, please describe these changes in your cover letter and we will update your Data Availability statement to reflect the information you provide.

Author response:

Ok, Thank you.

\[Note: HTML markup is below. Please do not edit.\]

Reviewers\' comments:

Reviewer\'s Responses to Questions

\#Comments to the Author

1\. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer \#1: No

Reviewer \#2: Yes

Reviewer \#3: Yes

Author response:

We thank the reviewers, as per the comments of the reviewers, changes were made to the article.

2\. Has the statistical analysis been performed appropriately and rigorously?

Reviewer \#1: No

Reviewer \#2: Yes

Reviewer \#3: Yes

Author response:

In accordance with the comments of reviewer 1, changes in the statistical analyses were made in the article

3\. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data---e.g. participant privacy or use of data from a third party---those must be specified.

Reviewer \#1: No

Reviewer \#2: Yes

Reviewer \#3: No

Author response:

In accordance with the comments, we now allow access to all anonymous research data, hence we will need to translate the information to English.

4\. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer \#1: Yes

Reviewer \#2: Yes

Reviewer \#3: Yes

Author response:

Thanks.

5\. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer \#1

Reviewer \#1: This study examines the association of ASD with preterm birth in 416 children from the ages of 2 to 11 years. More specifically, the authors seek to investigate the possibility of a gestational age gradient such that the risk of ASD decreases with each week of gestation from 24 to 37 weeks (from the lower boundary of extremely preterm to the upper boundary of later preterm) and how such a gradient might differ between males and females. They find that females have a significantly increased risk of ASD relative to males at lower gestational ages, whereas males maintain the same risk of ASD regardless of degree of prematurity.

Comments

1\. The authors' claim that such a gestational age gradient "has not been evidenced" in prior studies is inaccurate. At least two prior studies have demonstrated such a gradient (by week) with much larger epidemiological samples and with adjustment for a number of critical covariates and confounding variables that were not considered in the current study, presumably because the small sample size precluded their inclusion in statistical analyses. Please see Kuzniewicz et al., 2014 and Xie et al. (2017). In addition, Talmi et al. (2020) recently conducted a retrospective national cohort study of all children born in Israel from 2000-2012 using gestational age categories of extreme, very, moderate, and late preterm, showing a clear-cut gestational age gradient, as have a number of other large European population studies over the past decade, none of which are cited by the authors.

Author response:

We thank the reviewer for the constructive comments. We now addressed the aforementioned studies in our introduction. The analysis in the studies was categorical and divided prematurity in three large groups based on three levels of prematurity (uneven groups in terms of weeks- comparing two to six weeks clumped together). Other studies mentioned by the reviewer analyze birth weight and not gestational week. Our study offers risk data per each gestational week as a continuum and emphasizes the gender differences, which were not demonstrated in prior studies.

2\. The authors do not adequately address the loss to follow up of more than half of the sample (n=871) that was referred to them and the potential bias that this introduces into their results. At the very least, demographic and birth characteristics between those retained and those lost should be compared.

Author response:

Thank you, we added demographic and birth characteristics between those retained and those lost:

\"Of the 838 children identified who were born premature, 416 children were seen after the age of two years; 422 children were excluded. Of the excluded 229 (54.3%) were male, and 193 (45.7%) were female. The average birth week was 32.3 weeks (SD=2.5) and the average birth weight was 1670 grams (SD=486), which is significantly higher compared to children who were seen after the age of two years, t(834)=7.26, p\<0.001, t(819)=6.65, p\<0.001, respectively\".

3\. Fetal growth restriction has been found to contribute, independently of gestational age, to ASD risk in a number of high-quality studies. The lack of consideration of FGR/SGA in this study is problematic, especially in that FGR may represent a distinct preterm phenotype that confers ASD risk by different mechanisms than GA.

Author response:

Thank you for your comments, we re-analyzed the data. Effect for IUGR was not significant and the conclusions remained the same. We added:

\"We also examined IUGR/SGA. Thirty seven children had IUGR/SGA, 20 were males (54%) and 17 were females (46%). Birth week ranged from week 24-37, with an average of 30.8 weeks (SD= 3.9). Birth weight ranged from 580-2200 grams, with an average of 1130 grams (SD=448).

No correlation was found between IUGR/SGA and ASD, Ҳ² (1)=0.2, p\>.05., Thirty four of IUGR without ASD (92%) and 3 IUGR with ASD (8%). In order to examine whether IUGR had an effect on the results we exclude these 37 children from model. The model was significant Ҳ²(5)=17.74, p\<0.01, effect for IUGR was not significant Ҳ²(1)=0, p\>0.05 and the conclusions remained the same: the probability to ASD decreased for females with each birth week progress while for males it remained relatively constant\".

4\. The large age range is somewhat problematic in that the preterm ASD phenotype is not well characterized. ASD classifications in the youngest children, whether positive or negative, may not be stable.

Author response:

Thank you for affirming our approach, this is indeed the reason we included only the children that were in the 416 cohort, with confirmed ASD after age 2 years, in the model and multiple comparisons.

5\. It is now standard in autism epidemiological research to investigate ASD with and without intellectual disability (ID), as these are likely to differ to in etiology. The small sample size of the current study may have precluded meaningful statistical analysis addressing ID, but these data could have been presented for descriptive purposes. For example, one wonders how many of the EPT/VPT girls with ASD had ID and severe ID. The authors list a large number of cognitive measures, but they do not use these to describe their sample.

Author response:

Thank you for this important comment, the requested analysis strengthened significantly our model and revealed an important finding:

Indeed, we have followed your indication and examined the effect children with ID might have on the model, but found no contribution of this factor (ID) to the model. Moreover, children with ID were included in the group of 37 children with IUGR. Thus, by excluding them all in the model without IUGR and obtaining similar results, we confirm that no added effect is measured there.

Since the study group is young, we also added a model including GDD comorbidity (as a precursor of ID):

\"68 children (16.3%) received a diagnosis of GDD, thirteen of them have ASD (19%). Adding the GDD as an intervening factor to the model, strengthened the model slightly Ҳ²(6)=22.81, p\<0.001 and the GDD is significant Ҳ²(1)=6.48, p\<0.05 as well as its interaction with birth week and gender Ҳ²(1)=4.22, p\<0.05. When constructing a graph based on the nominal logistic model prediction, we see that while for females trends remain similar, the proportion of ASD drops as birth week increases. For females with GDD, the same trend is kept but with a higher propensity towards ASD. For males however, trends reverse. While for males without GDD the trend is relatively constant across birth weeks, for males with GDD the proportion of males with ASD increases with birth week (See Figure 4)\".

6\. The authors state that all ASD diagnoses were confirmed with the ADOS, but do not report any ADOS data, for example, the Modules used -- which would have given a better sense of the level of function in the sample -- or the severity scores for repetitive behaviors as well as social communicative impairment. These data are of interest in the characterization of any preterm ASD sample, given that the ADOS, a gold-standard measure, has rarely been used to characterize ASD in premies.

Author response:

Thank you, the ADOS data was not included since the sample comprised of young children. For most of the participants, Module 1 was used, more recently the Toddler adaptation for Module 1. Because of the age group and comorbidities related to prematurity, we assumed that severity data will not be conclusive. Based on the remarks, we are in the process of expanding the study and examining further the clinical symptoms of ASD in our premature group in comparison to a term group, but the results are beyond the scope of this paper.

7\. The rationale for investigating the GA gradient for global development delay (GDD) and CP in addition to ASD is not clearly or compellingly explained. It is not clear if these are overlapping or mutually exclusive groupings, although the latter seems to be the case. In addition, it is not reported if any of the children classified as ASD had severe ID or severe gross motor impairment. This is problematic in that DSM-5 excludes an ASD diagnosis that is "better explained by intellectual disability (intellectual developmental disorder) or global developmental delay", and it is not uncommon for EPT-born children to have this severity of ID. In addition, severe motor impairment (e.g., a Gross Motor Function Classification of Score = 5) could result in autism-like symptoms because of an inability to orient, direct attention, show, use gestures, etc.

Author response:

Thank you for your useful comments, we added:

\"68 children (16.3%) received a diagnosis of GDD, thirteen of them have ASD (19%). Adding the GDD as an intervening factor to the model, strengthened the model slightly Ҳ²(6)=22.81, p\<0.001 and the GDD is significant Ҳ²(1)=6.48, p\<0.05 as well as its interaction with birth week and gender Ҳ²(1)=4.22, p\<0.05. When constructing a graph based on the nominal logistic model prediction, we see that while for females trends remain similar, the proportion of ASD drops as birth week increases. For females with GDD, the same trend is kept but with a higher propensity towards ASD. For males however, trends reverse. While for males without GDD the trend is relatively constant across birth weeks, for males with GDD the proportion of males with ASD increases with birth week (See Figure 4)\".

In regards to children with an additional severe motor diagnosis we included it as a formal diagnosis of cerebral palsy. It is true that the clinical symptoms of severe CP or of global developmental delay may overlap with autism symptoms, but this is the main clinical expertise of our center- to be able to differentiate between CP or GDD as a main diagnosis verses CP or GDD as a comorbidity to an ASD diagnosis. Our diagnostic team is comprised not only of neurodevelopmental doctors and psychologists, but also occupational, language and physical therapists. We assess all children by formal assessments for all developmental diagnoses enabling specific and accurate differential diagnosis. Description of our assessment of CP was published in Gabis et al., 2015.

8\. The authors do not adequately account for multiple birth in their statistical analyses. Approximately, 44% of the sample and 44% of those diagnosed with ASD were multiples, with the large majorities of those twins. (Information on monozygosity was not available.) T-tests and chi-squares are used to analyze differences between singletons and multiples in mean GA and distributions by gestational age, respectively, but the results are difficult to follow and the authors do not offer a clear interpretation. It would seem more effective to have included this variable as a covariate in the logistic regression analysis. I also wondered how many of those classified with ASD were from the same birth.

Author response:

Thank you, we added:

\"Out of 184 multiple pregnancies 19 had ASD (10.3%). We examined the distribution of the proportion of multiple pregnancies with ASD across birth weeks but no particular significance was found between earlier and later birth weeks, nor were we able to construct a significant model indicating twins as a significant intervening factor Ҳ² (1)=1.52, p\>.05.\"

9\. It seems necessary to consider that the present findings are unreliable, given the small sample size and the inconsistency of the findings from a number of prior studies, which are not addressed in this report. It is notable, however, that others (e.g., Schendel & Bhasin; Xie et al., 2014) have found that females are at relatively higher risk of ASD with ID vs. without ID than males, which may bear on the current findings, if ID were taken into account.

Author response:

We thank the reviewer for the important comment. Indeed, similar findings suggestive of a relationship between prematurity and autism were found in other older studies (Schendel & Bhasin, 2008), and also newer studies (Xie et al., 2017). We discussed limitations and added value of our study in the introduction as referring to the above comment.

Reviewer \#2

Reviewer \#2: This manuscript explores the relationship of birth week among premature infants to Autism Spectrum Disorder (ASD), to see if the degree of prematurity might predict the likelihood that ASD might develop. 416 children born from 2011 to 2017, from an original cohort of 871 premature children, followed for at least two years were studied retrospectively, looking at birth week and gender. All children were from a single child development referral center in Israel. Nearly half were twins or triplets, some of whom may have been monozygotic. The authors acknowledge that this may have affected the risk for developing ASD. A total of 43 children were felt to have ASD, and the risk was greatest for those who were more premature. While the overall risk of developing ASD is greater for males than females, an elevated risk of ASD with lower birth week was greatest for females, who had a higher risk than males for lower birth weeks and a lower risk than males for higher birth weeks. For males, the risk was relatively stable across the range of birth weeks.

ASD is felt to be due to a combination of genetic and environmental factors, with brain insult and inflammation possibly contributing to the risk of developing it. Factors related to premature birth may contribute to the environmental components contributing to the development of ASD. Lower birth weight correlated with ASD risk in females, but not in males. A possible correlation between Cerebral Palsy (CP) and Global Developmental Delay (GDD) was also looked for. Measurements of ASD, CP and GDD by gender are shown across the range of birth weeks in the Figures 1-3. Table 1 summarizes the incidence of ASD by gender and birth week. A number of measures of cognitive function were utilized. Statistical analysis was appropriate.

This study shows that prematurity is a risk factor for the development of ASD, and provides additional information regarding the relative risk attributable to birth week and gender. It is beyond the scope of this study to look at specific factors that might contribute to the risk of ASD in premature children, such as anoxic brain damage, intraventricular hemorrhage, presence or absence of Retinopathy of Prematurity (ROP), and treatment of Type 1 ROP with anti-VEGF injections. What can be said is that earlier intervention for those developing ASD may contribute to better outcomes, and recognition of the increased risk of ASD in premature children is therefore important. It is an interesting study.

Author response:

Thank you

Reviewer \#3

Reviewer \#3: This is an interesting study with a retrospective look at prematurity and gender risk for ASD. There are several things that can strengthen it to make it more meaningful to autism researchers, clinician, and parents.

Abstract: Children were followed for only "at least" two years, so the statement about girls should may need to be tempered to say that this relationship is evident only for girls whose symptoms are sufficiently apparent to be diagnosed by the age of 24 months, if that was the case (no info is given on when they were diagnosed). Girls with higher cognitive and language abilities are often not diagnosed until much later.

Author response:

We agree, for this reason we limited the group to two years and above. Some of the girls were indeed diagnosed later, and as such included in the analysis. However we did not find a significant age difference in the age of diagnosis.

Introduction: When the manuscript is revised, the CDC prevalence data needs to be updated to 1:54. "significant risk of developmental risk" may need to be revised -- is developmental delay the intended meaning?

Author response:

Thank you for your attention, corrected.

Please clarify when the children were evaluated. It is stated that you only included children seen in the clinic up to the age of 2 to prevent loss to follow up, but several of the cognitive measures listed are for older children only. At what ages where the cognitive evaluations completed? It is apparent from the age range (2-14.2 years) that cognitive testing may have occurred at any point. This is a retrospective study, so presumably cognitive testing was done for a reason unrelated to the study, which should be addressed at least briefly to determine possibility of bias in the sample. For example, if the cognitive testing was performed as a matter of routine follow up for a premature child, that is less biased than if they were only performed when disability was suspected, introducing at least some selection bias in the sample. This issue is also related to the comment above about females across the spectrum who are typically not diagnosed until later in life.

Author response:

Thank you for your remark. The cognitive evaluation is performed initially during the initial diagnostic process and, according to the DSM-5 and MOH guidelines, is mandatory when a diagnosis of ASD made in order to establish that ID is not the main diagnosis (may accompany ASD). As such, all cognitive assessments were performed at the initial evaluation of autism and the instruments used are Mullen (up to age three) and IQ tests, such as WPPSI-III (until school age) and WISC-R (school age).

How old were the children when they were diagnosed? That is an important proxy for interpretation of the severity of the ASD.

Author response:

Thank you for your remark, we added age of diagnosis:

\"The age of initial ASD diagnosis was in the range of 1.1-8.5 years, with mean age of 3.5 years (SD=1.8)\".

Also, it would be helpful to know co-morbid diagnoses. Co-morbidity data would also aid in the interpretation of the findings. Are the females diagnosed with ASD in the lower gestational ages also affected by multiple disabilities or is ASD the primary risk? All of this information is more helpful than a blanket statement about risk and females as if they are all equivalent in terms of ASD. The current data are helpful, but MORE data from the records would significantly improve the interpretation and application of the study. Since Cognitive testing was completed, that is one example of data that aids in interpretation. Females with Intellectual Disability (ID) present very differently than females without ID, and may or may not have been identified yet to be included in the ASD data.

Author response:

Thank you, we examined the effect ID children might have on the model and each pair comparisons for significance but found no contribution of this factor (ID) to the model. Moreover, children with ID were all included in the group of 37 children with IUGR. Thus, by excluding them all in the model without IUGR children and obtaining similar results we confirm that no added effect is measured there. We also added a model with GDD:

\"68 children (16.3%) received a diagnosis of GDD, thirteen of them have ASD (19%). Adding the GDD as an intervening factor to the model strengthened the model slightly Ҳ²(6)=22.81, p\<0.001 and the GDD is significant Ҳ²(1)=6.48, p\<0.05 as well as its interaction with birth week and gender Ҳ²(1)=4.22, p\<0.05. When constructing a graph based on the nominal logistic model prediction, we see that while for females trends remain similar; the proportion of ASD drops as birth week increases, for females with GDD the same trend is kept but with a higher propensity to ASD. For males however, trends reverse; while for non GDD males the trend is relatively constant across birth weeks, for males with GDD the proportion of ASD males increases with birth week (See Figure 4)\".

Line 204 \-- What is the reference for "1:5 male/ female ratio of idiopathic autism"? And is this stated correctly? This sentence is used following presentation of the data of 20 males with ASD in the more advanced pregnancies compared to 4 females.

Author response:

Thank you, we added reference:

Gabis L V., Pomeroy J. An etiologic classification of autism spectrum disorders. Isr Med Assoc J. 2014;16(5):295--8.

Line 265 -- typo "especially form the less concerning group of patients born," there are other suspected typos throughout. (e.g. line 367 intervention. In: es, I., Levine J, editor. Neuroprotection in Autism, Schizophrenia and. . . )

Author response:

We thank the reviewer for turning our attention to the typos. Based on the reviewer's note we made the change to line 273, 397, and throughout the article.

Discussion: The discussion somewhat buries the lead in the statement (line 254) "However, after 33 weeks the incidence remains elevated and does not continue to decrease, following the pattern of increased risk in males, in the same gender distribution as \"idiopathic\" autism (33)"

Following that, it is surprisingly light on discussion of females with ASD, which is a very current topic in the autism community right now. Since the discussion acknowledges that the finding of sustained risk for males not only in prematurity but throughout gestation time is not novel, I think more discussion about the meaning of the finding for females is expected here, as that is the novel finding and the title of the article. Much is made of the findings for multiple births, which is also less than novel.

Author response:

Thank you very much for the opportunity to include our insights on gender differential vulnerability in the developing brain. We added a paragraph and new references in the discussion.

6\. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose "no", your identity will remain anonymous but your review may still be made public.

Author response: OK.

10.1371/journal.pone.0236994.r003
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Dear Dr. Gabis,

Thank you for submitting your revised manuscript to PLOS ONE. After careful consideration, there are still a few minor issues that will need to be addressed. In particular, one of the reviewers made the point that attrition could have affected your estimates. Please address this statistically or by noting in the text how this may impact your results and interpretations. The reviewer also noted a typo. Please proof your manuscript carefully as PLOS ONE will not copy edit your manuscript for typographical errors. 

Please submit your revised manuscript by Aug 23 2020 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at <plosone@plos.org>. When you\'re ready to submit your revision, log on to <https://www.editorialmanager.com/pone/> and select the \'Submissions Needing Revision\' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled \'Response to Reviewers\'.A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled \'Revised Manuscript with Track Changes\'.An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled \'Manuscript\'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: <http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols>

We look forward to receiving your revised manuscript.

Kind regards,

Eric J. Moody, Ph.D.

Academic Editor

PLOS ONE

\[Note: HTML markup is below. Please do not edit.\]

Reviewers\' comments:

Reviewer\'s Responses to Questions

**Comments to the Author**

1\. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the "Comments to the Author" section, enter your conflict of interest statement in the "Confidential to Editor" section, and submit your \"Accept\" recommendation.

Reviewer \#2: All comments have been addressed

Reviewer \#4: (No Response)

\*\*\*\*\*\*\*\*\*\*

2\. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer \#2: Yes

Reviewer \#4: Yes

\*\*\*\*\*\*\*\*\*\*

3\. Has the statistical analysis been performed appropriately and rigorously?

Reviewer \#2: Yes

Reviewer \#4: Yes

\*\*\*\*\*\*\*\*\*\*

4\. Have the authors made all data underlying the findings in their manuscript fully available?

The [PLOS Data policy](http://www.plosone.org/static/policies.action#sharing) requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data---e.g. participant privacy or use of data from a third party---those must be specified.

Reviewer \#2: Yes

Reviewer \#4: No

\*\*\*\*\*\*\*\*\*\*

5\. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer \#2: Yes

Reviewer \#4: Yes

\*\*\*\*\*\*\*\*\*\*

6\. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer \#2: I believe that the questons posed by the three reviewers have been adequately answered. I have nothing further to add, apart from my initial comments.

Reviewer \#4: line 287: the prevalence of ASD in the study sample could have been inflated by the high attrition rate (the infants without ASD are more likely to not coming back to the clinic.)

line 419: typo

\*\*\*\*\*\*\*\*\*\*

7\. PLOS authors have the option to publish the peer review history of their article ([what does this mean?](https://journals.plos.org/plosone/s/editorial-and-peer-review-process#loc-peer-review-history)). If published, this will include your full peer review and any attached files.

If you choose "no", your identity will remain anonymous but your review may still be made public.

**Do you want your identity to be public for this peer review?** For information about this choice, including consent withdrawal, please see our [Privacy Policy](https://www.plos.org/privacy-policy).

Reviewer \#2: No

Reviewer \#4: No

\[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link \"View Attachments\". If this link does not appear, there are no attachment files.\]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, <https://pacev2.apexcovantage.com/>. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at <figures@plos.org>. Please note that Supporting Information files do not need this step.
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6\. Review Comments to the Author

\#Comments to the Author

Reviewer \#2: I believe that the questions posed by the three reviewers have been adequately answered. I have nothing further to add, apart from my initial comments.

Author response: Thank you.

Reviewer \#4: line 287: the prevalence of ASD in the study sample could have been inflated by the high attrition rate (the infants without ASD are more likely to not coming back to the clinic.)

Author response:

Thank you for this very important remark and we will try to address it in different ways:

\- In regards to developmental follow up of non --ASD children, loss to follow up after the age of two years may be suspected for premature children with typical development, which may influence the rate of disability in the cohort. However, this may influence incidence of all developmental issues and not only ASD, since a high percentage of children born prematurely may have global developmental delay or delays in a single area of development.

\- This matter of declining numbers in the control cohort needs to be addressed, and is in the first steps of data exploration, as explained in the abstract in rows 29-30. In order to analyze this possible bias we recalculated the incidence for the whole cohort of 817 children followed from birth, including infants that did not reach two years. The same model and multiple comparisons were implemented and still showed similar significances as in the subset cohort of 416 children with a validated diagnosis of positive/ negative ASD. Within the 391 that were removed from the main analysis cohort of 416 children, there were 389 children with no ASD diagnosis, and 2 females born week 27 and 36 (\*10 exceptions excluded) with ASD. With this additional analysis, the principal conclusion was even strengthened- that the increased incidence with lower birth week is driven mainly by girls. So to answer the reviewer's comment, an increase in controls does not seem to affect the conclusion and vice versa.

\-

line 419: typo

Author response: Corrected, thank you.
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Dear Dr. Gabis,

We're pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you'll receive an e-mail detailing the required amendments. When these have been addressed, you'll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at <http://www.editorialmanager.com/pone/>, click the \'Update My Information\' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at <authorbilling@plos.org>.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they'll be preparing press materials, please inform our press team as soon as possible \-- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact <onepress@plos.org>.

Kind regards,

Eric J. Moody, Ph.D.

Academic Editor

PLOS ONE
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Dear Dr. Gabis:

I\'m pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they\'ll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact <onepress@plos.org>.

If we can help with anything else, please email us at <plosone@plos.org>.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff
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Dr. Eric J. Moody

Academic Editor

PLOS ONE
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